Substance P(1-7) (TFA) constitutes the N-terminal segment of Substance P, retaining key aromatic and basic residues that influence structural dynamics. Researchers use it to examine peptide-protein interfaces, β-turn formation, and solvent effects. The sequence provides insight into truncated peptide behavior. The TFA form allows predictable solvation for assays.
CAT No: R2205
CAS No:2828433-22-1
Synonyms/Alias:Substance P(1-7) (TFA);Substance P(1-7) TFA;2828433-22-1;(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoic acid;2,2,2-trifluoroacetic acid;1-7-Substance P trifluoroacetate;HY-P1485A;MS-31866;CS-0046306;G16494;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.